Hatch Waxman > Nova Content
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that... Read More »
Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging... Read More »
Small molecule drugs have been the norm for much of medicine’s history. Only in the past decade has there been a rise ... Read More »
On June 16, 2022, the World Trade Organization (WTO) agreed to a partial waiver of intellectual property rights related to... Read More »
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order to combat patent thickets... Read More »
NOVARTIS PHARMACEUTICALS CORP. V. HEC PHARM CO., LTD.
Before Moore, Hughes, and Linn (dissenting). Appeal from the United States... Read More »
The pandemic we just went through was one of the examples of how important is the patent system in strengthening the public health... Read More »
ResApp Health recently announced its planned sale to Pfizer Australia, a wholly owned subsidiary of Pfizer Inc. ... Read More »
Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound... Read More »
Last Friday, ImmunoGen won an appeal at the Federal Circuit in ImmunoGen, Inc. v. Hirshfeld. The lawsuit is a civil action to order... Read More »
ALMIRALL, LLC v. AMNEAL PHARMACEUTICALS LLC
Before Lourie, Chen, and Cunningham. Appeal from the Patent Trial and Appeal Board... Read More »
ADAPT PHARMA OPERATIONS LTD. V. TEVA PHARMS. USA, INC.
Before Newman, Prost, and Stoll. Appeal from the United States District Court for the District of New... Read More »
TEVA PHARMACEUTICALS USA, INC., v. CORCEPT THERAPEUTICS, INC.
Before Moore, Newman, and Reyna. Appeal from the Patent Trial and Appeal Board.
Summary... Read More »
ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC.
Before: Taranto, Hughes, and Stoll
Summary: For purposes of claim construction, intrinsic evidence... Read More »
Johnson & Johnson announced on November 12, 2021, that it is planning to separate its Consumer Health Business and create a new publicly traded Consumer... Read More »
BIOGEN INTERNATIONAL GMBH V. MYLAN PHARMACEUTICALS INC.
Before O’Malley, Reyna, and Hughes. Appeal from the United States District Court for the Northern... Read More »
INDIVIOR UK LIMITED v. DR. REDDY'S LABORATORIES S.A.
Before Lourie, Linn, and Dyk. Appeal from the Patent Trial and Appeal Board.
Summary: Claims of ... Read More »
Earlier in August, we released our second ANDA Litigation Intelligence Report. We analyzed all parties involved in Hatch-Waxman cases and ranked the top law firms and ... Read More »
In late August, we released our second annual ANDA Litigation Intelligence Report where we evaluated all stakeholders in Hatch-Waxman cases including ANDA attorneys... Read More »
BELCHER PHARMACEUTICALS v. HOSPIRA, INC.
Before Reyna, Taranto, and Stoll. Appeal from the District of Delaware.
Summary: A patentee committed... Read More »